医学
阿达木单抗
葡萄膜炎
不利影响
糖皮质激素
重症监护医学
皮肤病科
内科学
免疫学
疾病
作者
Glenn J. Jaffe,Andrew D. Dick,Antoine P. Brézin,Quan Dong Nguyen,Jennifer E. Thorne,Philippe Kestelyn,Talin Barisani-Asenbauer,Pablo Franco,Arnd Heiligenhaus,David K. Scales,David Chu,Anne Camez,Nisha V. Kwatra,Alexandra Song,Martina Kron,Samir Tari,Eric B. Suhler
标识
DOI:10.1056/nejmoa1509852
摘要
Patients with noninfectious uveitis are at risk for long-term complications of uncontrolled inflammation, as well as for the adverse effects of long-term glucocorticoid therapy. We conducted a trial to assess the efficacy and safety of adalimumab as a glucocorticoid-sparing agent for the treatment of noninfectious uveitis.
科研通智能强力驱动
Strongly Powered by AbleSci AI